ArticleBMC medicine2015
Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial.
Article in BMC medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02127567 (The Evaluation of a CONSORT Based Online Writing Tool), which is not on this map. Cited by 57 papers, 10 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Evaluation of a CONSORT Based Online Writing Tool: a Randomized Controlled Trial
Who cites it
57 citing papers in PubMed, 10 syntheses or guidelines pooled it.
- CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation.Ewha medical journal · 2025Guideline
- Adherence of SARS-CoV-2 Seroepidemiologic Studies to the ROSES-S Reporting Guideline During the COVID-19 Pandemic.Influenza and other respiratory viruses · 2024Pooled it
- ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi.PLoS medicine · 2024Guideline
- The endorsement of general and artificial intelligence reporting guidelines in radiological journals: a meta-research study.BMC medical research methodology · 2023Pooled it
- Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: cross sectional meta-research study.BMJ (Clinical research ed.) · 2022Pooled it
- Sex and gender considerations in reporting guidelines for health research: a systematic review.Biology of sex differences · 2021Pooled it
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.BMJ (Clinical research ed.) · 2021Guideline
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.Systematic reviews · 2021Guideline
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.PLoS medicine · 2021Guideline
- Pooled it
- There is no reliable evidence that providing authors with customized article templates including items from reporting guidelines improves completeness of reporting: the GoodReports randomized trial (GRReaT).BMC medical research methodology · 2025Trial
- Effect of an editorial intervention to improve the completeness of reporting of randomised trials: a randomised controlled trial.BMJ open · 2020Trial
- Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial.BMC medicine · 2016Trial
- Barriers and enablers for publishing results of randomized trials: a cross-sectional survey of principal investigators in sub-Saharan Africa.Research integrity and peer review · 2026Article
- Completeness of reporting in abstracts of randomized controlled trials and factors associated with complete reporting: a meta-research study.Research integrity and peer review · 2026Article
- A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology.Heart rhythm · 2025Review
- SPIRIT 2025 statement: updated guideline for protocols of randomized trials.Nature medicine · 2025Review
- SPIRIT 2025 statement: updated guideline for protocols of randomised trials.BMJ (Clinical research ed.) · 2025Article
- SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.BMJ (Clinical research ed.) · 2025Article
- CONSORT 2025 statement: updated guideline for reporting randomised trials.BMJ (Clinical research ed.) · 2025Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
backgroundIncomplete reporting is a frequent waste in research. Our aim was to evaluate the impact of a writing aid tool (WAT) based on the CONSORT statement and its extension for non-pharmacologic treatments on the completeness of reporting of randomized controlled trials (RCTs).
methodsWe performed a 'split-manuscript' RCT with blinded outcome assessment. Participants were masters and doctoral students in public health. They were asked to write, over a 4-hour period, the methods section of a manuscript based on a real RCT protocol, with a different protocol provided to each participant. Methods sections were divided into six different domains: 'trial design', 'randomization', 'blinding', 'participants', 'interventions', and 'outcomes'. Participants had to draft all six domains with access to the WAT for a random three of six domains. The random sequence was computer-generated and concealed. For each domain, the WAT comprised reminders of the corresponding CONSORT item(s), bullet points detailing all the key elements to be reported, and examples of good reporting. The control intervention consisted of no reminders. The primary outcome was the mean global score for completeness of reporting (scale 0-10) for all domains written with or without the WAT.
resultsForty-one participants wrote 41 different manuscripts of RCT methods sections, corresponding to 246 domains (six for each of the 41 protocols). All domains were analyzed. For the primary outcome, the mean (SD) global score for completeness of reporting was higher with than without use of the WAT: 7.1 (1.2) versus 5.0 (1.6), with a mean (95 % CI) difference 2.1 (1.5-2.7; P <0.01). Completeness of reporting was significantly higher with the WAT for all domains except for blinding and outcomes.
conclusionUse of the WAT could improve the completeness of manuscripts reporting the results of RCTs.
trial registrationClinicaltrials.gov ( http://clinicaltrials.gov NCT02127567 , registration date first received April 29, 2014).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.